A study published in JAMA Internal Medicine found that U.S. hospitals marked up the price of cancer therapies for patients with private health insurance, in some cases charging them more than seven times what it costs for hospitals to acquire the drugs, writes Healthcare Dive. The study Research over a six-month span last year shows prices varying considerably across payers and facilities, with the median drug price markup across all cancer centers and payers ranging between 118% and 634%. Researchers also found that most National Cancer Institute-designated facilities did not publicly disclose payer-specific prices for cancer therapies as required by federal price transparency regulations.
Read more:
- Healthcare Dive: https://www.healthcaredive.com/news/hospitals-markup-cancer-drugs-private-insurance-patientsjama/622317/
- Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance. JAMA Internal Medicine. April 22, 2022